HexylHIBO
Based on 1 Customer Validation
HexylHIBO is a potent group I mGluR antagonist with Kbs of 140 μM and 110 μM at mGlu1a and mGlu5a receptors, respectively. HexylHIBO does not inhibits mGlu2 and mGlu4a. HexylHIBO decreased spontaneous excitatory postsynaptic currents (sEPSCs) in rat.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- 純度 : 98.0%
- CAS 番号: 334887-43-3
- 分子式: C12H20N2O4
- 分子量:256.30
-
保管条件:Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
生物活性
製品説明
IC50 & Target
[1]|
mGluR1a 140 μM (Kb) |
mGluR5a 110 μM (Kb) |
体外実験
HexylHIBO (200 μM) reduces sEPSC amplitude by 28.7%[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. .
化学情報
-
CAS 番号 334887-43-3
-
性状 Solid
-
分子量 256.30
-
分子式 C12H20N2O4
-
Color Off-white to light yellow
-
SMILES
O=C(O)C(N)CC(ON1)=C(CCCCCC)C1=O
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month
溶剤 & 溶解度
体外:
DMSO : 100 mg/mL (390.17 mM; ultrasonic and warming and heat to 60°C; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
1M NaOH : 10 mg/mL (39.02 mM; Need ultrasonic and warming)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
純度とドキュメンテーション
-
データシート (275 KB)
-
SDS (393 KB)
- English - EN (393 KB)
- Français - FR (393 KB)
- Deutsch - DE (393 KB)
- Norwegian - NO (393 KB)
- Español - ES (393 KB)
- Swedish - SV (393 KB)
- Italian - IT (393 KB)
- Korean - KR (393 KB)
- Portuguese - PT (393 KB)
-
取扱説明書 (2659 KB)
参考文献
[1]. Madsen U, et al. Synthesis and pharmacology of 3-isoxazolol amino acids as selective antagonists at group I metabotropic glutamic acid receptors. J Med Chem. 2001;44(7):1051-1059. [Content Brief]
[2]. Bandrowski AE, et al, Prince DA. Baseline glutamate levels affect group I and II mGluRs in layer V pyramidal neurons of rat sensorimotor cortex. J Neurophysiol. 2003;89(3):1308-1316. [Content Brief]
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| 1M NaOH / DMSO | 1 mM | 3.9017 mL | 19.5084 mL | 39.0168 mL | 97.5419 mL |
| 5 mM | 0.7803 mL | 3.9017 mL | 7.8034 mL | 19.5084 mL | |
| 10 mM | 0.3902 mL | 1.9508 mL | 3.9017 mL | 9.7542 mL | |
| 15 mM | 0.2601 mL | 1.3006 mL | 2.6011 mL | 6.5028 mL | |
| 20 mM | 0.1951 mL | 0.9754 mL | 1.9508 mL | 4.8771 mL | |
| 25 mM | 0.1561 mL | 0.7803 mL | 1.5607 mL | 3.9017 mL | |
| 30 mM | 0.1301 mL | 0.6503 mL | 1.3006 mL | 3.2514 mL | |
| DMSO | 40 mM | 0.0975 mL | 0.4877 mL | 0.9754 mL | 2.4385 mL |
| 50 mM | 0.0780 mL | 0.3902 mL | 0.7803 mL | 1.9508 mL | |
| 60 mM | 0.0650 mL | 0.3251 mL | 0.6503 mL | 1.6257 mL | |
| 80 mM | 0.0488 mL | 0.2439 mL | 0.4877 mL | 1.2193 mL | |
| 100 mM | 0.0390 mL | 0.1951 mL | 0.3902 mL | 0.9754 mL |